Signaling pathways
-
BA9138 TegatrabetanSummary: Tegatrabetan (BC2059) is an antagonist. -
BA9139 ZW4864Summary: ZW4864 is an orally active and selective inhibitor of βcatenin/B-Celllymphoma9 protein-protein interactions. -
BA9140 NRX-252262Summary: NRX-252262 is a potent interaction enhancer with homologous SCF. -
BA9141 NRX-103094Summary: NRX-103094 is a potent interaction enhancer with homologous SCF. -
BA9142 β-catenin-IN-2Summary: β-catenin-IN-2 is a potent inhibitor of compound H1B1. -
BA9143 NRX-252114Summary: NRX-252114 is a potent interaction enhancer with homologous SCF. -
BA9145 NRX-2663Summary: NRX-2663 is an interaction enhancer with homologous SCF. -
BA9146 NRX-103095Summary: NRX-103095 is an interaction enhancer with homologous SCF. -
BA9147 β-catenin-IN-37Summary: β-catenin-IN-37 is a selective inhibitor of β-catenin/T-cellfactor protein interactions. -
BA9148 β-catenin-IN-6Summary: β-catenin-IN-6 is an inhibitor targeting the typical wingless-related integration site signaling pathway.
